AILERON THERAPEUTICS INC
Profile
Company Names
AILERON THERAPEUTICS INC
Addresses
738 MAIN STREET, UNIT 398, WALTHAM, MA 02451
281 ALBANY STREET, CAMBRIDGE, MA 02139
840 MEMORIAL DRIVE, 2ND FLOOR, CAMBRIDGE, MA 02139
Phone Numbers
617-995-0900
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$111,272,145.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-11-02
$18,254,247.00
$18,254,247.00
$0.00
Equity
4
2016-12-23
$30,112,894.00
$40,000,000.00
$9,887,106.00
Equity
3
2014-10-14
$19,799,999.00
$32,999,999.00
$13,200,000.00
Equity
2
2013-11-05
$15,000,003.00
$30,000,000.00
$14,999,997.00
Equity
1
2009-05-29
$28,105,002.00
$40,150,000.00
$12,044,998.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
REINHARD
J.
AMBROS
DIRECTOR
SETH
HARRISON
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC
| AILERON THERAPEUTICS INC
| HEARTWARE INTERNATIONAL, INC.
| APPLE TREE PARTNERS II - ANNEX, L.P.
| SYNTIMMUNE, INC.
| CURE FORWARD CORP.
| TUSKER MEDICAL, INC.
| GALA THERAPEUTICS, INC.
| GALAXY MEDICAL, INC.
| GALVANIZE THERAPEUTICS, INC.
| GALAVANT THERAPEUTICS, INC.
| OPAL BIOSCIENCES, INC.
| NINE SQUARE THERAPEUTICS, INC.
| APERTOR PHARMACEUTICALS, INC.
| INITIAL THERAPEUTICS, INC.
| NINE SQUARE THERAPEUTICS CORP
| REPLICATE BIOSCIENCE, INC.
| EVERCRISP BIOSCIENCES, INC.
| RED QUEEN THERAPEUTICS, INC.
| DEEP APPLE THERAPEUTICS, INC.
| GALVANIZE THERAPEUTICS, INC.
| MARLINSPIKE THERAPEUTICS, INC.
| AETHON THERAPEUTICS, INC.
| AULOS BIOSCIENCE, INC.
SETH
L.
HARRISON
DIRECTOR
SCOTT
KAPNICK
DIRECTOR
HIGHBRIDGE PRINCIPAL STRATEGIES - MEZZANINE PARTNERS II, L.P.
| HIGHBRIDGE PRINCIPAL STRATEGIES - OFFSHORE MEZZANINE PARTNERS II, L.P.
| HIGHBRIDGE PRINCIPAL STRATEGIES - INSTITUTIONAL MEZZANINE PARTNERS II, L.P.
| AILERON THERAPEUTICS INC
| HIGHBRIDGE PRINCIPAL STRATEGIES - REAL ESTATE CAPTIAL SOLUTIONS, L.P.
| HIGHBRIDGE PRINCIPAL STRATEGIES - REAL ESTATE CAPITAL SOLUTIONS OFFSHORE, L.P.
| HPS - MEZZANINE PARTNERS III, L.P.
| MEZZANINE PARTNERS III, L.P.
| HPS - OFFSHORE MEZZANINE PARTNERS III, L.P.
| OFFSHORE MEZZANINE PARTNERS III, L.P.
| HPS - AP MEZZANINE PARTNERS III, L.P.
| OFFSHORE MEZZANINE PARTNERS III INSTITUTIONAL, L.P.
| OFFSHORE MEZZANINE PARTNERS III CO-INVEST FEEDER, L.P.
| OFFSHORE MEZZANINE PARTNERS III CO-INVEST, L.P.
| PATRIOT CO-INVEST, L.P.
| EL SPECIALTY LOAN INSTITUTIONAL FUND 2016-L, L.P.
| WRANGLER CO-INVEST, L.P.
| GFL CO-INVEST, L.P.
| STAR CO-INVEST, L.P.
| STAR CO-INVEST II, L.P.
| NEPTUNE CO-INVEST, L.P.
| HPS SPECIAL SITUATIONS OPPORTUNITY OFFSHORE FUND, L.P.
| HPS SPECIAL SITUATIONS OPPORTUNITY FUND, L.P.
| HPS AD CO-INVESTMENT FUND, L.P.
| HPS MEZZANINE PARTNERS 2019, L.P.
| HPS OFFSHORE MEZZANINE PARTNERS 2019, L.P.
| HPS KP SIP V CO-INVESTMENT FUND, L.P.
| MINERVA CO-INVEST, L.P.
| HPS AP STRATEGIC INVESTMENT PARTNERS V, L.P.
| HPS OFFSHORE STRATEGIC INVESTMENT PARTNERS V, L.P.
| HPS STRATEGIC INVESTMENT PARTNERS V, L.P.
| HPS SPECIAL SITUATIONS OPPORTUNITY FUND II, L.P.
| HPS SUSTAINABILITY + ENERGY TRANSITION FUND FEEDER, L.P.
| HPS SUSTAINABILITY + ENERGY TRANSITION FUND, L.P.
| EL HPS SUSTAINABILITY + ENERGY TRANSITION FUND, L.P.
| HPS AP STRATEGIC INVESTMENT PARTNERS VI, L.P.
| HPS ASSET VALUE PLATFORM, L.P.
| HPS SIP VI HOOSIER CO-INVESTMENT FUND, L.P.
| HOLLYWOOD CO-INVEST, L.P.
| HOLLYWOOD OFFSHORE CO-INVEST, L.P.
| HPS STRATEGIC INVESTMENT PARTNERS VI, L.P.
CAMPBELL
MURRAY
DIRECTOR
ALIOS BIOPHARMA INC
| TOKAI PHARMACEUTICALS INC
| AILERON THERAPEUTICS INC
| BIORELIX INC
| EUTHYMICS BIOSCIENCE INC
| AKEBIA THERAPEUTICS, INC.
| AERPIO THERAPEUTICS, INC.
| NEUROVANCE, INC.
| EBI LIFE SCIENCES, INC.
| IMAGINAB, INC.
| GALERA THERAPEUTICS, INC.
| BIONANO GENOMICS, INC
| EUTHYMICS BIOSCIENCE, INC.
| ICEBREAKER HEALTH, INC.
| ANNEXON, INC.
| TSCAN THERAPEUTICS, INC.
| RENOVACOR, INC.
| LIGHTHOUSE PHARMACEUTICALS, INC.
ENRICO
PETRILLO
DIRECTOR
ARMEN
SHANAFELT
DIRECTOR
CALEB
WINDER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-11-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-12-23
